Both in Pharmaceuticals
AN2 Therapeutics vs MacroGenics
Over the past year ANTX returned +268.3% and MGNX returned +44.6%; their daily moves had a correlation of 0.17.
ANTX +268.3% MGNX +44.6%Growth of $1, one year, split-adjusted
| Metric | ANTX | MGNX |
|---|---|---|
| Price | $4.53 | $2.40 |
| Market cap | $170.9M | $152.9M |
| Today | −3.41% | +0.84% |
| 1 month | −19.4% | −33.3% |
| 6 months | −3.2% | −23.3% |
| Year to date | +297.4% | +49.1% |
| 1 year | +248.5% | +42.0% |
| Revenue growth (YoY) | — | +378.0% |
| Gross margin | — | 100.0% |
| Net margin | — | 59.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $78.4M | $173.3M |
| Dividend yield | — | — |
| Volatility (60d) | 74.5% | 113.8% |
| Short % of float | 10.0% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).